TFBS Bioscience Inc. (TPEX:6939)
Taiwan · Delayed Price · Currency is TWD 20.50
+0.25 (1.23%)
Apr 20, 2026, 1:21 PM CST
TFBS Bioscience Market Cap
TFBS Bioscience has a market cap or net worth of 698.78 million as of April 20, 2026. Its market cap has decreased by -30.03% in one year.
Market Cap
698.78M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
20.50
Market Cap Chart
Since May 15, 2023, TFBS Bioscience's market cap has decreased from 2.35B to 698.78M, a decrease of -70.25%. That is a compound annual growth rate of -33.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 698.78M | -6.54% |
| Dec 31, 2025 | 747.70M | -24.34% |
| Dec 31, 2024 | 988.18M | -39.96% |
| Dec 29, 2023 | 1.65B | -29.93% |
| May 15, 2023 | 2.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BIONET | 4.03B |
| DIVA Laboratories | 1.88B |
| Genetics Generation Advancement | 1.19B |
| Kim Forest Enterprise | 803.27M |
| Sofiva Genomics | 723.38M |
| Puriblood Medical | 712.92M |
| Pharmigene | 514.74M |
| Welgene Biotech | 434.62M |